These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Corticosteroid use for diabetic macular edema: old fad or new trend? Stewart MW Curr Diab Rep; 2012 Aug; 12(4):364-75. PubMed ID: 22581206 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344 [TBL] [Abstract][Full Text] [Related]
10. Monotherapy laser photocoagulation for diabetic macular oedema. Jorge EC; Jorge EN; Botelho M; Farat JG; Virgili G; El Dib R Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010859. PubMed ID: 30320466 [TBL] [Abstract][Full Text] [Related]
11. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema. Lee HY; Lee SY; Park JS Korean J Ophthalmol; 2009 Sep; 23(3):153-8. PubMed ID: 19794940 [TBL] [Abstract][Full Text] [Related]
12. The role of macular hydration in the evaluation of the effect of intravitreal triamcinolone on visual acuity in eyes with diabetic macular edema. Sonmez K; Tezel TH; Kaplan HJ Int Ophthalmol; 2013 Feb; 33(1):15-25. PubMed ID: 22890369 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis. Qi HP; Bi S; Wei SQ; Cui H; Zhao JB Curr Eye Res; 2012 Dec; 37(12):1136-47. PubMed ID: 22793880 [TBL] [Abstract][Full Text] [Related]
14. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema. Zein WM; Noureddin BN; Jurdi FA; Schakal A; Bashshur ZF Retina; 2006 Feb; 26(2):137-42. PubMed ID: 16467667 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial. Gillies MC; McAllister IL; Zhu M; Wong W; Louis D; Arnold JJ; Wong TY Invest Ophthalmol Vis Sci; 2010 May; 51(5):2322-8. PubMed ID: 20019369 [TBL] [Abstract][Full Text] [Related]
17. The effects and safety of intravitreal triamcinolone injections in the treatment of diabetic macular edema. Zając-Pytrus HM; Kaczmarek R; Strońska-Lipowicz D; Pomorska M; Misiuk-Hojło M Adv Clin Exp Med; 2017; 26(1):45-49. PubMed ID: 28397431 [TBL] [Abstract][Full Text] [Related]
18. The effects of intravitreal triamcinolone acetonide in diabetic macular edema refractory to anti-VEGF treatment. Hong IH; Choi W; Han JR Jpn J Ophthalmol; 2020 Mar; 64(2):196-202. PubMed ID: 31900869 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema. Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127 [TBL] [Abstract][Full Text] [Related]
20. Comparison of intravitreal preservative-free triamcinolone versus posterior sub-tenon triamcinolone acetonide injection for bevacizumab-resistant diabetic macular edema. Jeon SH; Kim M; Roh YJ BMC Ophthalmol; 2024 Jan; 24(1):25. PubMed ID: 38243166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]